5-fluorouracil and methotrexate combination chemotherapy: The effect of drug scheduling
β Scribed by Mulder, J.H.; Smink, T.; Van Putten, L.M.
- Book ID
- 123214571
- Publisher
- Elsevier Science
- Year
- 1981
- Weight
- 509 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0277-5379
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Because of conflicting reports of clinical synergy, we used the tetrazolium-based colorimetric (MTT) assay to test in vitro combination effects of methotrexate (MTX) plus 5fluorouracil (FUra) in 4 schedules on 2 human non-small-cell lung cancer cell lines (adenocarcinoma, NCLH23; bronchioalveolar-ce
## Abstract The CMF regimen, which is clinically used in adjuvant therapy of breast cancer, is known to be carcinogenic in rats (Habs and SchmΓ€hl, 1981). To examine alternative regimens, a longβterm carcinogenicity study was performed, using the VMF regimen as follows: V (i.v.), M (i.p.) and F (p.o
Male Fl hybrid rats bearing the R-3327 transplantable prostatic adenocarcinoma demonstrating similar growth patterns within the original sample of animals were carefully separated into control and treatment groups. This assured treatment of tumors with similar cell kinetics within each group. In the